Gérard Désilets retweeted
Francophonie: le Québec dans le monde | JDM journaldemontreal.com/2026/1…
Gérard Désilets retweeted
Rod Emmerson @rodemmerson on #Trump #Putin – political cartoon gallery in London original-political-cartoon.c…
Gérard Désilets retweeted
Once you realize he works for Russia, not America, everything he does makes sense.
#TraitorTrump
Gérard Désilets retweeted
La caricature d'Ygreck | Le Journal de Montréal journaldemontreal.com/2026/1…
Gérard Désilets retweeted
Researchers have engineered a synthetic protein that does not exist in nature and used it to neutralize an entire family of food allergens at once. Many allergy-triggering proteins found in peaches, apples, hazelnuts, and almonds belong to a single molecular group known as non-specific lipid transfer proteins. Because these proteins share a remarkably similar structural shape, an individual allergic to one food frequently suffers cross-reactive allergic responses to the others.
To tackle this widespread cross-reactivity, a team at the Technical University of Denmark computationally averaged the shared structural features of these proteins into a single artificial consensus allergen. They then encoded the genetic instructions for this synthetic molecule into an mRNA vaccine platform similar to COVID-19 shots, prompting the body's own cells to manufacture the harmless lookalike protein and train the immune system to tolerate it.
Published in Nature Communications, the preclinical results show strong immune reprogramming. Healthy mice generated high levels of protective IgG antibodies after a single injection, and following three doses, those antibodies successfully recognized and bound to a wide spectrum of related plant allergens. In sensitized allergic mice, protective antibody levels climbed sharply with virtually no adverse side effects, and laboratory assays confirmed that these antibodies suppressed allergic reactions in blood samples donated by human allergy patients.
For most individuals living with severe food allergies, the only established treatment currently available involves years of oral immunotherapy, slowly ingesting tiny, escalating doses of a single trigger food, which offers zero protection against related foods that activate the same immune pathway. A vaccine capable of neutralizing an entire allergen family simultaneously would transform allergy care, and the research team is already developing a second candidate targeting the protein family responsible for apple, carrot, and hazelnut allergies.
Crucially, the researchers emphasize that this work remains a preclinical proof of concept in mice. At the specific doses tested, the vaccine did not fully prevent anaphylaxis, the life-threatening whole-body reaction that makes food allergies so dangerous, and the formulation has not yet been tested in humans. Moving forward, the team aims to optimize dosing schedules in larger animal studies and compile the safety data required by regulators before launching a first-in-human clinical trial.
[Moiniche, M., Rivera de Torre, E., et al. (2026). An mRNA-delivered consensus allergen induces a neutralizing IgG response against food and pollen allergens. Nature Communications]
Gérard Désilets retweeted
Meta, Apple, Google et Signal contestent le projet de loi C-22, qui élargirait l’accès des autorités canadiennes à certaines données numériques. Au cœur du débat : jusqu’où Ottawa peut-il aller pour faciliter les enquêtes sans affaiblir la confidentialité et la sécurité des communications ? moncarnet.com/2026/11/17/pro…
🤖 Made with AI































